FDA Arthritis Advisory Committee meeting: guidelines for clinical evaluation of therapies for scleroderma.
Paulus
H E
HE
UCLA School of Medicine, Department of Medicine 90024-1670.
D002985:Clinical Protocols; D005069:Evaluation Studies as Topic; D006801:Humans; D015203:Reproducibility of Results; D012595:Scleroderma, Systemic / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration